Whilst I haven't done my comparative analysis for a while I now think SOL is headed into my buy range. I think that this is turning out to be a bad investment for MLT investors. My reasoning is. They got a 10% above NTA at the Higher value of SOL pegged @$31.00 So essentially their cost at $31 is $28.18. Many as I pointed out before want an LIC investment. This is a hybrid. They would have been excited when the deal was done but since then SOL has retreated from its highs. So from 21 October 2021 ARG is up 8% and SOL is down 16.34%. That is not good for the new shareholders. The crossover point is $28.18 for a SOL share ( that excludes the SOL dividend - shareholders exclude the money that have received - grubby capitalists - lol). Today closed at $28.41. I am waiting for capitulation. I would assume many retirees are watching this and saying that they should have sold earlier and bought ARG or AFI. They would in fact be better off. I am kicking myself for not switching and waiting for the capitulation and switching back in my SMSF.
At this price the horse, cart and buggy have bolted so I will await a rerating.
What I am very interested in is that at this price and if it comes down a bit more I will be very excited as I think SOL is now a unique product that has a lot more stability so that I can increase my portfolio weighting. There is substantially less risk. Huge portfolio underpinning the projects. I would just like them to exit/reduce Vodafone when allowed.
I will be a buyer if it gets below $28.00
- Forums
- ASX - By Stock
- SOL
- Ann: 2021 AGM Presentation
SOL
washington h soul pattinson & company limited
Add to My Watchlist
0.60%
!
$41.78

Ann: 2021 AGM Presentation, page-48
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$41.78 |
Change
0.250(0.60%) |
Mkt cap ! $15.36B |
Open | High | Low | Value | Volume |
$41.61 | $42.00 | $41.41 | $15.66M | 374.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4117 | $41.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$41.90 | 1300 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4117 | 41.780 |
1 | 2214 | 41.740 |
1 | 979 | 41.710 |
2 | 2336 | 41.690 |
1 | 743 | 41.670 |
Price($) | Vol. | No. |
---|---|---|
41.900 | 1300 | 1 |
41.910 | 149 | 1 |
41.960 | 2452 | 1 |
41.980 | 704 | 1 |
42.000 | 3306 | 6 |
Last trade - 16.13pm 26/06/2025 (20 minute delay) ? |
Featured News
SOL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online